Crescita Therapeutics (CTX) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CTX Stock Alerts C$0.42 0.00 (0.00%) (As of 05/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | finance.yahoo.comCrescita Reports First Quarter 2024 ResultsApril 18, 2024 | seekingalpha.comCTNM Contineum Therapeutics, Inc.March 13, 2024 | finance.yahoo.comCrescita Reports Q4 and Fiscal 2023 ResultsFebruary 17, 2024 | morningstar.comCrescita Therapeutics Inc CTXDecember 14, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Wednesday (CTX)November 8, 2023 | finance.yahoo.comCrescita Reports Third Quarter 2023 ResultsNovember 4, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Thursday (CTX)September 30, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Friday (CTX)September 1, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Tuesday (CTX)August 9, 2023 | finance.yahoo.comCrescita Reports Second Quarter 2023 ResultsAugust 6, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Monday (CTX)July 29, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Friday (CTX)July 18, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Monday (CTX)June 8, 2023 | finance.yahoo.comSubdued Growth No Barrier To Crescita Therapeutics Inc.'s (TSE:CTX) PriceJune 1, 2023 | finance.yahoo.comCroma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeMay 11, 2023 | finance.yahoo.comCrescita Reports First Quarter 2023 ResultsApril 15, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Friday (CTX)April 12, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc up on Tuesday (CTX)April 11, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Thursday (CTX)April 8, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc flat on Wednesday (CTX)April 6, 2023 | theglobeandmail.comClosing Bell: Crescita Therapeutics Inc down on Wednesday (CTX)March 18, 2023 | seekingalpha.comCrescita Therapeutics GAAP EPS of C$0.06, revenue of C$6MMarch 15, 2023 | finanznachrichten.deCrescita Therapeutics Inc. Reports Q4 and Fiscal 2022 ResultsMarch 15, 2023 | msn.comCrescita Therapeutics GAAP EPS of $0.06, revenue of $6MMarch 15, 2023 | markets.businessinsider.comCrescita Therapeutics Q4 Profit Rises, But Revenues DeclineMarch 15, 2023 | finance.yahoo.comCrescita Reports Q4 and Fiscal 2022 ResultsNovember 16, 2022 | seekingalpha.comCTX:CA Crescita Therapeutics Inc.November 11, 2022 | finance.yahoo.comCrescita Therapeutics Third Quarter 2022 Earnings: EPS: CA$0.009 (vs CA$0.043 loss in 3Q 2021)November 9, 2022 | finance.yahoo.comCrescita Reports Third Quarter 2022 ResultsAugust 12, 2022 | seekingalpha.comCrescita Therapeutics GAAP EPS of C$0.00, revenue of C$6.51MAugust 10, 2022 | reuters.comCrescita Therapeutics IncAugust 10, 2022 | finance.yahoo.comCrescita Reports Second Quarter 2022 ResultsAugust 6, 2022 | ca.finance.yahoo.comCrescita Therapeutics Inc. (CTX.TO)May 11, 2022 | finance.yahoo.comCrescita Reports First Quarter 2022 ResultsApril 21, 2022 | financialpost.comCrescita to Present at Bloom Burton & Co. Healthcare Investor ConferenceMarch 23, 2022 | finance.yahoo.comCrescita Reports Q4 and Fiscal 2021 ResultsDecember 19, 2021 | ca.finance.yahoo.comStocks in play: Crescita Therapeutics Inc.December 13, 2021 | finance.yahoo.comCrescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®December 2, 2021 | investing.comCrescita Therapeutics Inc (CTX)November 11, 2021 | finance.yahoo.comCrescita Reports Third Quarter 2021 Results and Appoints New Board MemberSeptember 9, 2021 | finance.yahoo.comCrescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLCSeptember 7, 2021 | businesswire.comCrescita Acquires Minority Interest in The Best YouSeptember 7, 2021 | nasdaq.comCrescita Completes Buying Minority Interest In The Best YouSeptember 7, 2021 | finance.yahoo.comCrescita Acquires Minority Interest in The Best You®August 18, 2021 | finance.yahoo.comCrescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis®August 11, 2021 | finance.yahoo.comCrescita Reports Second Quarter 2021 Results and Provides Corporate Update Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. CTX Media Mentions By Week CTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTX News Sentiment▼0.000.76▲Average Medical News Sentiment CTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTX Articles This Week▼00▲CTX Articles Average Week Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LABS News MPH News NDVA News WLLW News VPH News AH News ENTG News AQS News VIV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
